| Cordarone X Intravenous, 150mg/3ml, Concentrate for solution for infusion or slow injection PA0540/142/003 |
Amiodarone hydrochloride |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Dulcolax 10 mg Suppositories PA23180/018/002 |
Bisacodyl |
Opella Healthcare France SAS T/A Sanofi |
Marketed |
| Dulcolax 5mg Gastro-resistant Tablets PA23180/018/003 |
Bisacodyl |
Opella Healthcare France SAS T/A Sanofi |
Marketed |
| Dulcolax Pico Liquid 5 mg/5 ml oral solution PA23180/017/001 |
Sodium picosulfate |
Opella Healthcare France SAS T/A Sanofi |
Marketed |
| DuoPlavin 75 mg/100 mg film-coated tablets EU/1/10/619/008-014 |
Acetylsalicylic acid, Clopidogrel hydrogensulfate |
Sanofi Winthrop Industrie |
— |
| DuoPlavin 75 mg/75 mg film-coated tablets EU/1/10/619/01-07 |
Acetylsalicylic acid, Clopidogrel hydrogensulfate |
Sanofi Winthrop Industrie |
— |
| Dupixent EU/1/17/1229/021-022 |
Dupilumab |
Sanofi Winthrop Industrie |
— |
| Dupixent 200 mg solution for injection in pre-filled pen EU/1/17/1229/023-025 |
Dupilumab |
Sanofi Winthrop Industrie |
— |
| Dupixent 200 mg solution for injection in pre-filled syringe EU/1/17/1229/009-0016 |
Dupilumab |
Sanofi Winthrop Industrie |
— |
| Dupixent 300 mg solution for injection in pre-filled pen EU/1/17/1229/026-028 |
Dupilumab |
Sanofi Winthrop Industrie |
— |
| Dupixent 300 mg solution for injection in pre-filled syringe EU/1/17/1229/001-008 |
Dupilumab |
Sanofi Winthrop Industrie |
— |
| Efluelda suspension for injection in pre-filled syringe Trivalent influenza vaccine (split virion, inactivated), 60 micrograms HA/strain PA23458/001/001 |
Influenza Inactivated Split Virus Strain A (H1N1), Influenza Inactivated Split Virus Strain A (H3N2), Influenza Inactivated Split Virus Strain B |
Sanofi Winthrop Industrie |
Not marketed |
| Efluelda Tetra, suspension for injection in pre-filled syringe PA23458/012/001 |
Influenza Inactivated Split Virus Strain B, Influenza Inactivated Split Virus Strain A (H3N2), Influenza Inactivated Split Virus Strain B, Influenza Inactivated Split Virus Strain A (H1N1) |
Sanofi Winthrop Industrie |
Not marketed |
| Epilim 100 mg Crushable Tablets PA0540/150/001 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chrono 200mg Prolonged Release Tablets PA0540/150/010 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chrono 300mg Prolonged Release Tablets PA0540/150/011 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chrono 500mg Prolonged Release Tablets PA0540/150/012 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chronosphere 100mg prolonged-release granules PA0540/150/005 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chronosphere 250mg prolonged-release granules PA0540/150/006 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Chronosphere 500mg prolonged-release granules PA0540/150/007 |
Sodium valproate, Valproic acid |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Enteric 200 mg gastro-resistant coated tablets PA0540/150/002 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Enteric 500mg Gastro-resistant Coated Tablets PA0540/150/003 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Intravenous 400mg powder and solvent for solution for injection or infusion PA0540/150/013 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Liquid 200 mg/5ml Oral Solution PA0540/150/014 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Epilim Syrup 200mg/5ml Oral Solution PA0540/150/015 |
Sodium valproate |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Evoltra 1 mg/ml concentrate for solution for infusion EU/1/06/334/01-05 |
Clofarabine |
Sanofi B.V. |
— |
| Fabrazyme 35 mg powder for concentrate for solution for infusion EU/1/01/188/001-003 |
Agalsidase Beta |
Sanofi B.V. |
— |
| Fabrazyme 5 mg powder for concentrate for solution for infusion EU/1/01/188/004-006 |
Protein c agalsidase beta (recombinant human-a-galactoside a) |
Sanofi B.V. |
— |
| Fasturtec 1.5 mg/ml powder and solvent for concentrate for solution for infusion EU/1/00/170/001-002 |
Rasburicase |
Sanofi Winthrop Industrie |
— |
| Fludara 10 mg film-coated tablets PA0611/004/002 |
Fludarabine phosphate |
Sanofi B.V. |
Not marketed |
| Frumil 40mg/5mg Tablets PA0540/101/002 |
Furosemide, AMILORIDE HYDROCHLORIDE |
Sanofi-Aventis Ireland Limited T/A SANOFI |
Marketed |
| Hexacima suspension for injection EU/1/13/828/001-007 |
Haemophilus influenzae type b capsular polysaccharide, Pertussis toxoid, (polyribosylribitol phosphate) conjugated to tetanous protein, Filamentous haemagglutinin, Type 1 (mahoney) |
Sanofi Winthrop Industrie |
— |
| Hexyon suspension for injection EU/1/13/829/001-007 |
(polyribosylribitol phosphate) conjugated to tetanous protein, Type 1 (mahoney), Haemophilus influenzae type b polysaccharide, Diphtheria toxoid, Type 2 (mef-1) |
Sanofi Winthrop Industrie |
— |
| Insulin aspart Sanofi EU/1/20/1447/001-005 |
Insulin aspart |
Sanofi Winthrop Industrie |
— |
| Insulin aspart Sanofi EU/1/20/1447/001-007 |
Insulin aspart |
Sanofi Winthrop Industrie |
— |
| Insulin lispro Sanofi 100 units/ml solution for injection EU/1/17/1203/001-008 |
Insulin lispro |
Sanofi Winthrop Industrie |
— |
| Insuman Basal 100 IU/ml suspension for injection in a cartridge EU/1/97/030/035 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 100 IU/ml suspension for injection in a cartridge EU/1/97/030/057 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 100 IU/ml suspension for injection in a cartridge EU/1/97/030/058 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 100 IU/ml suspension for injection in a vial EU/1/97/030/033 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 100 IU/ml suspension for injection in a vial EU/1/97/030/034 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 40 IU/ml suspension for injection in a vial EU/1/97/030/036 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Basal 40 IU/ml suspension for injection in a vial EU/1/97/030/037 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 15 100 IU/ml suspension for injection in a cartridge EU/1/97/030/040 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 15 100 IU/ml suspension for injection in a cartridge EU/1/97/030/059 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 15 100 IU/ml suspension for injection in a cartridge EU/1/97/030/060 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 15 100 IU/ml suspension for injection in a vial EU/1/97/030/038 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 15 100 IU/ml suspension for injection in a vial EU/1/97/030/039 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 25 100 IU/ml suspension for injection in a cartridge EU/1/97/030/045 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |
| Insuman Comb 25 100 IU/ml suspension for injection in a cartridge EU/1/97/030/061 |
Insulin human |
Sanofi-Aventis Deutschland GmbH |
— |